[Pj-05] Japanese Poster Session 05 Muscle diseases 01

[Pj-05-8] Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in LOPD patients

^○Hitoshi Nagura¹, Akihiro Arimori¹, Priya Kishnani², Shahram Attarian³, Joao Lindolfo Borges⁴, Francoise Bouhour⁵, Yin-hsiu Chien⁶, Young-chul Choi⁷, Paula Clemens⁸, John Day⁹, Jordi Diaz-manera¹⁰, Sevim Erdem-ozdamar¹¹, Ozlem Goker-alpan¹², Sergey Illarioshkin¹³, Anna Kostera-pruszczyk¹⁴, Hani Kushlaf¹⁵, Shafeeq Ladha¹⁶, Tahseen Mozaffar¹⁷, Mark Roberts¹⁸, Volker Straub¹⁹, Antonio Toscano²⁰, Ans Van Der Ploeg²¹, Kristina An Haack²², Benedikt Schoser²³, COMET Study Group²⁴ (1.Sanofi K.K., Japan, 2.Duke University Medical Center, 3.Hôpital La Timone, 4.Clinical Research Center of Brazil, 5.Pierre Wertheimer Hospital, 6.National Taiwan University Hospital, 7.Yonsei University, 8.University of Pittsburgh, 9.Stanford University, 10.Newcastle University, 11.Hacettepe University, 12.O and O Alpan LLC, 13.Research Center of Neurology, 14.Medical University of Warsaw, 15.University of Cincinnati, 16.Barrow Neurological Institute, 17.University of California, 18.Salford Royal NHS Foundation Trust, 19.Newcastle University, 20.University of Messina, 21.Erasmus MC, 22.Sanofi Genzyme, 23.Klinikum München, 24.COMET Study Group)